Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05281237 · ClinicalTrials.gov registry record · NA
Avecure Flexible Microwave Ablation Probe For Lung Nodules
A NA study of Lung Cancer and Lung Cancer Stage II, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05281237 is a NA study of Lung Cancer and Lung Cancer Stage II that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 10 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05281237, a NA study of Lung Cancer and Lung Cancer Stage II, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size. This research study involves microwave ablation (MWA)
Conditions Studied
Interventions
- DEVICE AveCure 16 Gauge Flexible Microwave Ablation Probe
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05281237
The ClinicalTrials.gov registry entry for NCT05281237 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which AveCure 16 Gauge Flexible Microwave Ablation Probe is the first listed.
NCT05281237 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05281237 about?
NCT05281237 is a clinical study titled "Avecure Flexible Microwave Ablation Probe For Lung Nodules". This research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size. This research study involves microwave ablation (MWA)
What is the current status of trial NCT05281237?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2022-06-01. Estimated completion is 2027-06-30.
What conditions does trial NCT05281237 study?
This clinical trial studies the following conditions: Lung Cancer, Lung Cancer Stage II, Stage II Lung Cancer, Lung Cancer Stage I, Stage I Lung Cancer.
What interventions are being tested in trial NCT05281237?
The interventions under investigation include: AveCure 16 Gauge Flexible Microwave Ablation Probe (DEVICE).
Who is sponsoring clinical trial NCT05281237?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05281237 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.